Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 144,927 | 33,215 |
| Gross Profit | N/A | N/A | N/A | 144,927 | 33,215 |
| Operating Expenses | 121,315 | 195,097 | 179,914 | 209,420 | 121,345 |
| Operating Income | -121,315 | -195,097 | -179,914 | -64,493 | -88,130 |
| Interest Expense | 0 | 2,468 | 6,020 | 2,910 | 2,924 |
| Other Income | -4,456 | 7,435 | 2,353 | 1,825 | 1,927 |
| Pre-tax Income | -125,771 | -190,130 | -183,581 | -65,578 | -89,127 |
| Net Income Continuous | -125,771 | -190,130 | -183,581 | -65,578 | -89,127 |
| Net Income Discontinuous | 125,907 | 76,406 | -66,576 | N/A | N/A |
| Net Income | $136 | $-113,724 | $-250,157 | $-65,578 | $-89,127 |
| EPS Basic Total Ops | 0.00 | -17.80 | -46.20 | -14.40 | -22.40 |
| EPS Basic Continuous Ops | -16.20 | -29.80 | -34.00 | -14.30 | -22.34 |
| EPS Basic Discontinuous Ops | 16.20 | 12.00 | -12.40 | N/A | N/A |
| EPS Diluted Total Ops | 0.00 | -17.80 | -46.20 | -14.40 | -22.40 |
| EPS Diluted Continuous Ops | -16.20 | -29.80 | -34.00 | -14.30 | -22.34 |
| EPS Diluted Discontinuous Ops | 16.20 | 12.00 | -12.40 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -16.20 | -17.80 | -46.20 | -14.40 | -22.40 |
| EBITDA(a) | $-114,434 | $-187,951 | $-171,892 | $-55,522 | $-80,555 |